Time for a reassessment of the use of Kava in anxiety?

J. Sarris; J. Adams; J. L. Wardle

doi:10.1016/j.ctim.2009.01.003

Time for a reassessment of the use of Kava in anxiety?

J. Sarris, J. Adams, J. L. Wardle

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Abstract

Seven years after the ongoing ban of Piper methysticum (Kava) by the EU, UK and Canada: Where are we at? In December 2008, articles by the Fiji Times reported that the Kava ban was over-turned. This statement was subsequently revealed to be erroneous and is indicative of the controversy and confusion sometimes surrounding regulatory, safety and efficacy issues associated with Kava.

Original language	English
Pages (from-to)	121-122
Number of pages	2
Journal	Complementary Therapies in Medicine
Volume	17
Issue number	3
DOIs	https://doi.org/10.1016/j.ctim.2009.01.003
Publication status	Published - 2009

Keywords

Kava plant
anxiety
phytotherapy

Access to Document

10.1016/j.ctim.2009.01.003

Cite this

@article{37aaa9ac90c140a9a1d0733d003bcb61,

title = "Time for a reassessment of the use of Kava in anxiety?",

abstract = "Seven years after the ongoing ban of Piper methysticum (Kava) by the EU, UK and Canada: Where are we at? In December 2008, articles by the Fiji Times reported that the Kava ban was over-turned. This statement was subsequently revealed to be erroneous and is indicative of the controversy and confusion sometimes surrounding regulatory, safety and efficacy issues associated with Kava.",

keywords = "Kava plant, anxiety, phytotherapy",

author = "J. Sarris and J. Adams and Wardle, {J. L.}",

year = "2009",

doi = "10.1016/j.ctim.2009.01.003",

language = "English",

volume = "17",

pages = "121--122",

journal = "Complementary Therapies in Medicine",

issn = "1873-6963",